In 2021, the market worth of breast reconstruction was USD 2.68 billion, and by 2030, it will reach USD 4.98 billion, expanding at a 7.11% CAGR during the forecast period.
Breast reconstruction surgery restores the breast shape after a mastectomy or any procedure to address congenital disabilities. The market will expand due to the growing need for various breast reconstruction surgical procedures, such as nipple prostheses, mammoplasty, mastectomy, lumpectomy, etc. In order to lower their risk of developing breast cancer, more than 100,000 women in the U.S. get a mastectomy each year, according to Brigham and Women’s Hospital.
More than 3.1 million people in the U.S. have successfully battled breast cancer, according to the American Society of Plastic Surgeons. Less than 50% of the women who need a good mastectomy receive the greatest breast reconstruction procedures worldwide each year.
A major factor stimulating the growth of the market is the rising rate of breast cancer. Breast cancer is the most prevalent diagnosed cancer worldwide, according to GLOBOCAN 2020. The WHO estimates that 2.3 million women will receive a breast cancer diagnosis worldwide in 2020. Over the past five years, over 7.8 million women have been diagnosed with breast cancer. Breast cancer was common in Asian women, accounting for 22.9% of all cancer cases in women in 2020. Growing awareness about breast reconstruction options’ safety encourages women to undergo mastectomy.
The market is growing due to the rise in innovative items. For instance, G.C. Aesthetics introduced Perle, a cutting-edge round breast implant, in October 2020. Reverse surface technology was used in its development, resulting in less irritation and simpler implantation and incision. The advent of such cutting-edge breast implants will boost market expansion
The development of the global breast reconstruction market is hampered by the availability of non-surgical alternatives and the high cost of breast reconstruction utilizing implants.
The market will have considerable growth prospects due to quick technological improvements, strong growth potential in emerging regions, and the rising popularity of 3D-printed implants. Also, skin-sparing mastectomy is getting more popular all over the world and is quickly moving toward being the norm in the field of breast reconstruction.
Based on the product, the market for breast reconstruction is segmented into saline implants, silicone implants, implants, and tissue expanders. Implants ruled the market with 60.0% of the revenue share in 2021. As a result, more people have breast augmentation treatments, including breast implants. For instance, according to the NCBI, 8.08 out of every 1,000 American women currently get breast implants. Moreover, the University of Utah Health estimates that almost 35 million women have textured breast implants. Additionally, more than 1.5 million women get implants annually.
The healthcare industry had the biggest revenue share in 2021 due to the expansion of hospitals worldwide. For instance, the Athar Institute of Health Management & Studies estimates that hospitals comprise approximately 80% of India’s healthcare business. Moreover, medical tourism has increased on a global scale. As a result, hospitals will offer higher-quality medical services with the rapid growth of medical tourism.
In 2021, North America was the largest market regionally, with a significant revenue share. The largest share is due to the region’s highly established healthcare infrastructure. An increase in healthcare spending will fuel market expansion throughout the forecast period. The expansion of the global breast reconstruction market in the North American area is driven by factors such as rising breast cancer occurrences, raising awareness of breast reconstruction, and FDA approvals for breast reconstruction products.
Asia Pacific is the second-largest regional market and will expand rapidly. The rise in breast cancer prevalence and the high demand for breast implants drive the growth of the market in this area. Players are increasingly releasing new products in nations like Japan, China, India, and Australia. The region’s breast construction market will grow as disposable income increases, and surgical treatments become more widely available in hospitals and ambulatory surgical facilities.
- Johnson & Johnson
- Allergan Inc.
- PMT Corporation
- Mentor Worldwide LLC
- GC Aesthetics
- POLYTECH Health & Aesthetics GmbH
- Ideal Implant Incorporated
- DPS Technology Development Ltd
- AbbVie Inc.
- Establishment Labs S.A.
- Arion Laboratories
- HANSBIOMED CO. LTD
- Integra Lifesciences
- KOKEN CO. LTD.
In 2021, the market worth of breast reconstruction was USD 2.68 billion, and by 2030 it will reach USD 4.98 billion, expanding at a 7.11% CAGR during the forecast period. The rise in breast cancer patients and the availability of advantageous reimbursement rules drive market expansion. Also, the market will grow as a result of technological advancements and an increase in the number of breast reconstruction treatments.
Organ Preservation Market Report – The global organ preservation market will witness a robust CAGR of 6.93%, valued at $206.89 million in 2021, expected to appreciate and reach $377.97 million by 2030, confirms Strategic Market Research. Organ preservation may be defined as storing a donated organ in specially prepared conditions that can be taken out when organ transplantation needs to be performed.